A carregar...
Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer
Colorectal cancer (CRC) is one of the most leading causes of cancer-related death worldwide. The serum and glucocorticoid inducible kinase SGK1 is highly expressed and involved in several tumors. GSK650394, a SGK1 inhibitor, has been proved to be effective in impeding tumor growth in vitro. In this...
Na minha lista:
Publicado no: | J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Ivyspring International Publisher
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5560143/ https://ncbi.nlm.nih.gov/pubmed/28819428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19566 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|